Latest News about PFE
Recent news which mentions PFE
From MarketWatch
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
October 16, 2023
From Benzinga
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
October 16, 2023
From Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
From Benzinga
Moderna confirms COVID sales guidance as shares sink on Pfizer news
October 16, 2023
From MarketWatch
From Benzinga
2 Big-Name Stocks Making Monday Morning Moves
October 16, 2023
From Motley Fool
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
From Benzinga
Pfizer Cuts Annual Revenue Guidance By $9B Amid COVID-19 Vaccine Sales Slump, BioNTech Warns €900M Write-Offs
October 16, 2023
From Benzinga
It’s earnings season. Why Netflix and Nvidia have been crossed off this firm’s list for quality stocks.
October 16, 2023
From MarketWatch
Cut Your Losses: Sell These 7 Weak Stocks Now
October 16, 2023
From InvestorPlace
Is Novavax Stock a Buy Now?
October 16, 2023
From Motley Fool
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
October 16, 2023
From MarketWatch
Pfizer, Charles Schwab And 3 Stocks To Watch Heading Into Monday
October 16, 2023
From Benzinga
2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
October 15, 2023
From Motley Fool
Pfizer’s stock sinks after company cuts outlook on lower demand for COVID treatments
October 13, 2023
From MarketWatch
From Benzinga
From InvestorPlace
ABBV Stock: Buy for the Yield, Hold for This Other Reason
October 13, 2023
From InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
October 12, 2023
From Benzinga
3 Stocks That Are Down Big, But Are Due to Fall Much Further
October 12, 2023
From InvestorPlace
PFE Stock Warning: Avoid This Big Pharma Value Trap at All Costs
October 12, 2023
Tickers
PFE
From InvestorPlace
Exxon’s $59.5 billion deal for Pioneer Natural Resources tops 2023 deals in moribund M&A market
October 11, 2023
From MarketWatch
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
From Motley Fool
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 10, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.